State AGs Oppose Generic Drug Firms’ Certiorari Bid Over Discovery Procedure
WASHINGTON, D.C. — Defending a discovery process established in a multidistrict litigation over generic drug price-fixing, a group of respondents, headed up by a coalition of state attorneys general (AGs) filed...To view the full article, register now.
Already a subscriber? Click here to view full article